Search research articles
Contact Us
Filters
Showing results (61-70 of 81) with videos related to
Page
of 9
Sort By:
Plos One
|
November 22, 2013
A cell-free fluorometric high-throughput screen for inhibitors of Rtt109-catalyzed histone acetylation
Jayme L Dahlin, Rondedrick Sinville, Jonathan Solberg, et al.
Journal of Medicinal Chemistry
|
August 18, 2020
The Essential Medicinal Chemistry of Cannabidiol (CBD)
Kathryn M Nelson, Jonathan Bisson, Gurpreet Singh, et al.
British Journal of Haematology
|
May 21, 2025
Long-term efficacy and safety of mitapivat in non-transfusion-dependent α- or β-thalassaemia: An open-label phase 2 study
Kevin H M Kuo, D Mark Layton, Ashutosh Lal, et al.
European Journal of Medicinal Chemistry
|
August 31, 2025
Development of potent glutathione transferase Omega-1 inhibitors with applications in inflammation and cancer therapy
Yiyue Xie, Yuji Nakano, Padmaja Tummala, et al.
SLAS Technology
|
November 23, 2021
Cross-Platform Bayesian Optimization System for Autonomous Biological Assay Development
Sam Elder, Carleen Klumpp-Thomas, Adam Yasgar, et al.
Journal of Medicinal Chemistry
|
February 28, 2020
Development of Benzenesulfonamide Derivatives as Potent Glutathione Transferase Omega-1 Inhibitors
Yiyue Xie, Padmaja Tummala, Aaron J Oakley, et al.
Osteoarthritis and Cartilage
|
July 11, 2014
Osteochondral defect repair using bilayered hydrogels encapsulating both chondrogenically and osteogenically pre-differentiated mesenchymal stem cells in a rabbit model
J Lam, S Lu, E J Lee, et al.
Journal of Biomedical Materials Research. Part A
|
July 30, 2013
Tissue response to composite hydrogels for vertical bone augmentation in the rat
Lucas A Kinard, Rebecca L Dahlin, Allan M Henslee, et al.
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
Nonspecific membrane bilayer perturbations by ivermectin underlie SARS-CoV-2 <i>in vitro</i> activity
Richard T Eastman, Radda Rusinova, Karl F Herold, et al.
Nature Communications
|
November 17, 2017
Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors
Jayme L Dahlin, Kathryn M Nelson, Jessica M Strasser, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 81) with videos related to
Sort By:
Page
of 9
Plos One
|
November 22, 2013
A cell-free fluorometric high-throughput screen for inhibitors of Rtt109-catalyzed histone acetylation
Jayme L Dahlin, Rondedrick Sinville, Jonathan Solberg, et al.
Journal of Medicinal Chemistry
|
August 18, 2020
The Essential Medicinal Chemistry of Cannabidiol (CBD)
Kathryn M Nelson, Jonathan Bisson, Gurpreet Singh, et al.
British Journal of Haematology
|
May 21, 2025
Long-term efficacy and safety of mitapivat in non-transfusion-dependent α- or β-thalassaemia: An open-label phase 2 study
Kevin H M Kuo, D Mark Layton, Ashutosh Lal, et al.
European Journal of Medicinal Chemistry
|
August 31, 2025
Development of potent glutathione transferase Omega-1 inhibitors with applications in inflammation and cancer therapy
Yiyue Xie, Yuji Nakano, Padmaja Tummala, et al.
SLAS Technology
|
November 23, 2021
Cross-Platform Bayesian Optimization System for Autonomous Biological Assay Development
Sam Elder, Carleen Klumpp-Thomas, Adam Yasgar, et al.
Journal of Medicinal Chemistry
|
February 28, 2020
Development of Benzenesulfonamide Derivatives as Potent Glutathione Transferase Omega-1 Inhibitors
Yiyue Xie, Padmaja Tummala, Aaron J Oakley, et al.
Osteoarthritis and Cartilage
|
July 11, 2014
Osteochondral defect repair using bilayered hydrogels encapsulating both chondrogenically and osteogenically pre-differentiated mesenchymal stem cells in a rabbit model
J Lam, S Lu, E J Lee, et al.
Journal of Biomedical Materials Research. Part A
|
July 30, 2013
Tissue response to composite hydrogels for vertical bone augmentation in the rat
Lucas A Kinard, Rebecca L Dahlin, Allan M Henslee, et al.
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
Nonspecific membrane bilayer perturbations by ivermectin underlie SARS-CoV-2 <i>in vitro</i> activity
Richard T Eastman, Radda Rusinova, Karl F Herold, et al.
Nature Communications
|
November 17, 2017
Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors
Jayme L Dahlin, Kathryn M Nelson, Jessica M Strasser, et al.
Page
of 9